Loading...Loading...A National Coverage Determination (NCD) is a federal mandate of what Medicare covers. View the full NCD summary for each topic on the Centers for Medicare & Medicaid Services (CMS) website using the links below.
To view older NCDs, visit the CMS website Medicare Coverage Database
Preexposure Prophylaxis (PrEP) using Antiretroviral Therapy to Prevent Human Immunodeficiency Virus (HIV) Infection
The Centers for Medicare & Medicaid Services (CMS) has determined that Pre-Exposure Prophylaxis (PrEP) using antiretroviral drugs to prevent Human Immunodeficiency Virus (HIV) is covered as an additional preventive service…
Effective for services performed on or after March 6, 2024, allogeneic hematopoietic stem cell transplant…
Stem Cell Transplantation
The Centers for Medicare & Medicaid Services (CMS) finds that coverage of percutaneous transluminal angioplasty (PTA) of the carotid artery concurrent with stenting is reasonable and necessary…
Percutaneous Transluminal Angioplasty (PTA) of the Carotid Artery Concurrent with Stenting
Effective for services performed on or after May 16, 2023, power seat elevation equipment is reasonable and necessary for individuals using complex rehabilitative power-driven wheelchairs…
Seat Elevation Equipment on Power Wheelchairs
Effective January 1, 2023, the minimum age for FOBT, sDNA, and blood-based biomarker tests for colorectal cancer screening is reduced to 45 years and older...
National Coverage Determination, Colorectal Cancer Screening Tests
May 19, 2022
CMS has determined that the evidence is sufficient to cover, under Medicare Part B, a lung cancer screening counseling and shared decision-making visit, and for appropriate beneficiaries, annual screening for lung cancer with LDCT…
National Coverage Determination, Lung Cancer Screening with LDCT
Last updated 10/01/2024
Y0062_2025_MEDICARE